Among ICU patients with acute hypoxemic respiratory failure, high-flow nasal oxygen reduced the incidence of intubation but did not significantly reduce 28-day mortality compared with standard oxygen ...

According to Vapotherm, its protocol also demonstrated the feasibility of examining pediatric emergency situations using delayed informed consent. (JazzIRT/GettyImage) Children, as well as their ...

A new process mapping study reveals the behavioral and contextual drivers behind inappropriate high-flow nasal cannula use in ...

Common clinical scenariosA patient hospitalized with pneumonia. Even with a reservoir mask at 10 L/min, SpO2 is 89%.

Please provide your email address to receive an email when new articles are posted on . Patients with severe interstitial lung disease who received heated and humidified nasal high-flow oxygen therapy ...

The American College of Physicians (ACP) today released a new Clinical Guideline with recommendations for the appropriate use of high-flow nasal oxygen in hospitalized patients for initial or ...

A randomized pilot study finds that high-flow tracheal oxygen increases inspiratory effort without diaphragmatic harm in ...

IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...

In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...

SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...

Rising respiratory disease burden, demand for non-invasive support, wider acute-care use, and opportunities in home care, emerging economies, and portable systems drive HFNC adoption.Dublin, Oct.